1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. ADAPTIMMUNE THERAPEUTICS PLC - ADR

Adaptimmune Therapeutics Plc - ADR XNAS: ADAP

Adaptimmune Therapeutics Plc - ADR Live Share Price Today, Share Analysis and Chart

Weak Stock
about

Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer target...

Read More

0.27 -0.01 (-3.57%)

81.76% Fall from 52W High

375.6K XNAS Volume

XNAS 22 May, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
Board Meeting
The next board meeting for Adaptimmune Therapeutics Plc - ADR is on 29 May 2025 for the purpose of Adaptimmune Therapeutics PLC Annual General Meeting for 2025 See details
Durability score
Low Financial Strength
11.1 / 100
Valuation Score
Expensive Valuation
15.7 / 100
Momentum Score
Technically Bearish
30.0 / 100
Weak Stock These stocks are the ones with poor quality, financials and technicals. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM
Analyst Price Target
2
1Yr Price target upside is 485%
8 analysts

8

S

17

W

0

O

3

T

SWOT Analysis

Adaptimmune Therapeutics P... Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..

Adaptimmune Therapeutics Plc - ADR FAQ

How is Adaptimmune Therapeutics Plc - ADR today?
Adaptimmune Therapeutics Plc - ADR today is trading in the red, and is down by -3.57% at 0.27.
Adaptimmune Therapeutics Plc - ADR is currently trading down -3.57% on an intraday basis. In the past week the stock fell 0.00%. stock has been down -51.79% in the past quarter and fell -75.00% in the past year. You can view this in the overview section.